US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Azitra Inc

0.1328

+0.00614.81%

Post-market: 0.1321-0.0007-0.53%19:50 EDT

Volume:2.00M

Turnover:270.51K

Market Cap:8.05M

PE:-0.10

High:0.1405

Open:0.1350

Low:0.1300

Close:0.1267

52wk High:1.40

52wk Low:0.1000

Shares:60.60M

Float Shares:54.32M

Volume Ratio:2.69

T/O Rate:3.68%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.3022

EPS(LYR):-2.2479

ROE:-256.67%

ROA:-119.91%

PB:1.10

PE(LYR):-0.06

Loading ...

Overview Company News Filings

Azitra, Inc. Announces Q1 2026 Results and Provides Business Updates

THOMSON REUTERS

Azitra Q1 FY26 net loss widens to $3.9 million; G&A expenses rise to $2.4 million

Azitra wins new US patent protecting ATR-12 Netherton syndrome program

Azitra, Inc. Announces New U.S. Patent Protecting Atr-12 Program

THOMSON REUTERS

Azitra presents preclinical ATR-01 data supporting first-in-human ichthyosis vulgaris trial planning

Azitra prices private placement for up to USD 31 million

Why Is Azitra Inc Stock (AZTR) Up Today?

Azitra Reports Private Placement Deal

MT Newswires Live

Azitra Inc trading resumes

Azitra prices private placement financing of up to USD 31.4 million

Press Release: Azitra Announces Pricing of Private Placement Financing of up to Approximately $10.5 Million with up to an Additional Approximately $20.9 Million

Amex Halt News Pending Lst 0.137400

THOMSON REUTERS

Azitra Receives Notice of Non-Compliance From Nyse American and Makes Nyse American Section 610(B) Public Announcement

THOMSON REUTERS

Azitra Receives NYSE American Non-Compliance Notice on Stockholders’ Equity Requirement

Azitra Delays Shareholder Meeting to March 6, 2026

Anitra Q4 EPS $(0.81) Misses $(0.33) Estimate

Benzinga Earnings

Press Release: Azitra, Inc. Announces Full Year 2025 Results and Provides Business Updates

Azitra posts FY 2025 net loss of USD 11.0 million

Azitra FY 2025 net loss attributable to common shareholders widens 22% to USD 11.0 million

Azitra Adds MD Anderson Cancer Center as ATR-04 Trial Site

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/AZTR/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AZTR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZTR\",,,,,undefined,":{"symbol":"AZTR","market":"US","secType":"STK","nameCN":"Azitra Inc","latestPrice":0.1328,"timestamp":1787342400000,"preClose":0.1267,"halted":0,"volume":1999566,"hourTrading":{"tag":"盘后","latestPrice":0.1321,"preClose":0.1328,"latestTime":"19:50 EDT","volume":44005,"amount":5776.23059,"timestamp":1787356226455,"change":-0.0007,"changeRate":-0.005271,"amplitude":0.042922},"delay":0,"changeRate":0.048145224940805004,"floatShares":54324100,"shares":60603700,"eps":-1.3022,"marketStatus":"Market Closed","change":0.0061,"latestTime":"08-21 16:00:00 EDT","open":0.135,"high":0.1405,"low":0.13,"amount":270507.8870478,"amplitude":0.082873,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.3022,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1684382400000,"exchange":"AMEX","adjPreClose":0.1267,"preHourTrading":{"tag":"盘前","latestPrice":0.1337,"preClose":0.1267,"latestTime":"09:29 EDT","volume":417891,"amount":56048.15104086,"timestamp":1787318951575,"change":0.007,"changeRate":0.055249,"amplitude":0.061563},"postHourTrading":{"tag":"盘后","latestPrice":0.1321,"preClose":0.1328,"latestTime":"19:50 EDT","volume":44005,"amount":5776.23059,"timestamp":1787356226455,"change":-0.0007,"changeRate":-0.005271,"amplitude":0.042922},"volumeRatio":2.689456144024451},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZTR\",,,,,undefined,":{"symbol":"AZTR","floatShares":54324100,"roa":"-119.91%","roe":"-256.67%","lyrEps":-2.247923,"volumeRatio":2.689456144024451,"shares":60603700,"dividePrice":0,"high":0.1405,"amplitude":0.082873,"preClose":0.1267,"low":0.13,"week52Low":0.1,"pbRate":"1.10","week52High":1.4,"institutionHeld":0,"latestPrice":0.1328,"eps":-1.3022,"divideRate":0,"volume":1999566,"delay":0,"ttmEps":-1.3022,"open":0.135,"prevYearClose":0.2648,"prevWeekClose":0.1393,"prevMonthClose":0.1327,"prevQuarterClose":0.1678,"fiveDayClose":0.1393,"twentyDayClose":0.1263,"sixtyDayClose":0.2066},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AZTR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-21","symbol":"AZTR","defaultRemindTime":1755783000000,"type":"split","dateTimestamp":1755748800000,"forFactor":666,"toFactor":100,"ratio":6.66},{"market":"US","date":"2024-07-01","symbol":"AZTR","defaultRemindTime":1719840600000,"type":"split","dateTimestamp":1719806400000,"forFactor":30,"toFactor":1,"ratio":30}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AZTR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AZTR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1758772800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AZTR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AZTR","date":"2026-08-21","current":-0.101981,"percent":0.22179,"low":-5.58964,"twenty":-0.93575,"median":-0.430342,"eighty":-0.279558,"high":-0.115438,"avg":-0.741777,"sd":0.934256,"marketCap":7678494},"quantilePoints":[{"date":"2023-06-16","current":-5.58964,"twenty":-5.58964,"median":-5.58964,"eighty":-5.58964,"marketCap":60432550},{"date":"2023-06-23","current":-5.399592,"twenty":-5.535979,"median":-5.477847,"eighty":-5.319101,"marketCap":58377843},{"date":"2023-06-30","current":-4.158692,"twenty":-5.495734,"median":-4.997138,"eighty":-4.683,"marketCap":44961817},{"date":"2023-07-07","current":-4.102796,"twenty":-5.446545,"median":-4.779142,"eighty":-4.362155,"marketCap":44357491},{"date":"2023-07-14","current":-4.516429,"twenty":-5.23861,"median":-4.527608,"eighty":-4.362155,"marketCap":48829500},{"date":"2023-07-21","current":-4.471712,"twenty":-4.912176,"median":-4.545495,"eighty":-4.476184,"marketCap":48346040},{"date":"2023-07-28","current":-4.046899,"twenty":-4.782496,"median":-4.527608,"eighty":-4.268249,"marketCap":43753166},{"date":"2023-08-04","current":-2.683027,"twenty":-4.767963,"median":-4.499884,"eighty":-4.151985,"marketCap":29007624},{"date":"2023-08-11","current":-3.040764,"twenty":-4.731474,"median":-4.477302,"eighty":-4.060314,"marketCap":32875307},{"date":"2023-08-18","current":-2.775015,"twenty":-4.690311,"median":-4.281664,"eighty":-3.058651,"marketCap":30002154},{"date":"2023-08-25","current":-1.902871,"twenty":-4.641637,"median":-4.231357,"eighty":-2.884254,"marketCap":25405050},{"date":"2023-09-01","current":-1.803197,"twenty":-4.5827,"median":-4.147513,"eighty":-2.714329,"marketCap":24074309},{"date":"2023-09-08","current":-1.902871,"twenty":-4.560878,"median":-4.102796,"eighty":-2.060538,"marketCap":25405050},{"date":"2023-09-15","current":-1.585817,"twenty":-4.544154,"median":-3.834493,"eighty":-1.953615,"marketCap":21172085},{"date":"2023-09-21","current":-1.61291,"twenty":-4.538788,"median":-3.091071,"eighty":-1.911933,"marketCap":21533804},{"date":"2023-09-29","current":-1.449807,"twenty":-4.516429,"median":-3.018406,"eighty":-1.812258,"marketCap":19356228},{"date":"2023-10-06","current":-1.359194,"twenty":-4.516429,"median":-2.884254,"eighty":-1.757891,"marketCap":18146464},{"date":"2023-10-13","current":-1.223274,"twenty":-4.499884,"median":-2.775015,"eighty":-1.61291,"marketCap":16331818},{"date":"2023-10-20","current":-1.631033,"twenty":-4.482891,"median":-2.442461,"eighty":-1.531358,"marketCap":21775757},{"date":"2023-10-27","current":-1.495113,"twenty":-4.482891,"median":-2.138465,"eighty":-1.509611,"marketCap":19961110},{"date":"2023-11-03","current":-1.40441,"twenty":-4.478419,"median":-1.984423,"eighty":-1.435308,"marketCap":18750136},{"date":"2023-11-10","current":-1.694462,"twenty":-4.458297,"median":-1.96177,"eighty":-1.420811,"marketCap":22622592},{"date":"2023-11-17","current":-1.465632,"twenty":-4.37557,"median":-1.920994,"eighty":-1.431684,"marketCap":18872323},{"date":"2023-11-24","current":-1.211965,"twenty":-4.277192,"median":-1.902871,"eighty":-1.413562,"marketCap":15605959},{"date":"2023-12-01","current":-0.977088,"twenty":-4.25707,"median":-1.832646,"eighty":-1.395439,"marketCap":12581548},{"date":"2023-12-08","current":-0.920718,"twenty":-4.241419,"median":-1.803197,"eighty":-1.359194,"marketCap":11855690},{"date":"2023-12-15","current":-1.343496,"twenty":-4.20341,"median":-1.74883,"eighty":-1.354152,"marketCap":17299629},{"date":"2023-12-22","current":-1.207362,"twenty":-4.156456,"median":-1.638553,"eighty":-1.313887,"marketCap":15546681},{"date":"2023-12-29","current":-0.995972,"twenty":-4.149749,"median":-1.634793,"eighty":-1.283368,"marketCap":12824711},{"date":"2024-01-05","current":-0.995878,"twenty":-4.143041,"median":-1.631033,"eighty":-1.233783,"marketCap":12823501},{"date":"2024-01-12","current":-0.972391,"twenty":-4.122919,"median":-1.585771,"eighty":-1.215761,"marketCap":12521060},{"date":"2024-01-19","current":-1.925991,"twenty":-4.098324,"median":-1.585771,"eighty":-1.213863,"marketCap":24800168},{"date":"2024-01-26","current":-1.249546,"twenty":-4.073729,"median":-1.531358,"eighty":-1.221818,"marketCap":16089865},{"date":"2024-02-02","current":-1.089829,"twenty":-3.961937,"median":-1.519884,"eighty":-1.211965,"marketCap":14033265},{"date":"2024-02-09","current":-0.967693,"twenty":-3.517002,"median":-1.493818,"eighty":-1.195054,"marketCap":12460572},{"date":"2024-02-16","current":-0.833723,"twenty":-3.094425,"median":-1.466781,"eighty":-1.167586,"marketCap":10735497},{"date":"2024-02-23","current":-0.571872,"twenty":-3.085481,"median":-1.465632,"eighty":-1.12741,"marketCap":7363748},{"date":"2024-03-01","current":-0.569638,"twenty":-3.040764,"median":-1.449807,"eighty":-1.080434,"marketCap":7334983},{"date":"2024-03-08","current":-0.5091,"twenty":-3.018406,"median":-1.436214,"eighty":-1.024064,"marketCap":6555462},{"date":"2024-03-15","current":-0.533896,"twenty":-2.973688,"median":-1.413562,"eighty":-0.986483,"marketCap":6874749},{"date":"2024-03-22","current":-0.577176,"twenty":-2.884254,"median":-1.406836,"eighty":-0.977088,"marketCap":6512729},{"date":"2024-03-28","current":-0.512081,"twenty":-2.884254,"median":-1.395439,"eighty":-0.95454,"marketCap":5778211},{"date":"2024-04-05","current":-0.602448,"twenty":-2.82165,"median":-1.381077,"eighty":-0.91696,"marketCap":6797895},{"date":"2024-04-12","current":-0.465876,"twenty":-2.781212,"median":-1.359194,"eighty":-0.858373,"marketCap":5256847},{"date":"2024-04-19","current":-0.484509,"twenty":-2.764029,"median":-1.359194,"eighty":-0.602141,"marketCap":5467092},{"date":"2024-04-26","current":-0.56186,"twenty":-2.698678,"median":-1.348194,"eighty":-0.592185,"marketCap":6339901},{"date":"2024-05-03","current":-0.561349,"twenty":-2.298121,"median":-1.33201,"eighty":-0.590246,"marketCap":6334140},{"date":"2024-05-10","current":-0.634358,"twenty":-2.100408,"median":-1.309357,"eighty":-0.590246,"marketCap":7157953},{"date":"2024-05-17","current":-0.485733,"twenty":-2.060538,"median":-1.287126,"eighty":-0.577789,"marketCap":5711960},{"date":"2024-05-24","current":-0.495041,"twenty":-1.998921,"median":-1.258941,"eighty":-0.571425,"marketCap":5821418},{"date":"2024-05-31","current":-0.477649,"twenty":-1.978986,"median":-1.23641,"eighty":-0.56671,"marketCap":5616905},{"date":"2024-06-07","current":-0.40441,"twenty":-1.975362,"median":-1.223274,"eighty":-0.560644,"marketCap":4755646},{"date":"2024-06-14","current":-0.355665,"twenty":-1.964488,"median":-1.211965,"eighty":-0.547207,"marketCap":4182434},{"date":"2024-06-21","current":-0.348806,"twenty":-1.948178,"median":-1.211965,"eighty":-0.531751,"marketCap":4101781},{"date":"2024-06-28","current":-0.323332,"twenty":-1.948178,"median":-1.207362,"eighty":-0.527437,"marketCap":3802212},{"date":"2024-07-05","current":-0.191876,"twenty":-1.946474,"median":-1.193175,"eighty":-0.519324,"marketCap":2256361},{"date":"2024-07-12","current":-0.262095,"twenty":-1.936747,"median":-1.171479,"eighty":-0.513791,"marketCap":3082094},{"date":"2024-07-15","current":-0.249847,"twenty":-1.933161,"median":-1.16499,"eighty":-0.513107,"marketCap":2938071},{"date":"2024-08-02","current":-0.505188,"twenty":-1.929576,"median":-1.160292,"eighty":-0.511877,"marketCap":5940751},{"date":"2024-08-09","current":-0.326677,"twenty":-1.921993,"median":-1.12741,"eighty":-0.508698,"marketCap":3841548},{"date":"2024-08-16","current":-0.508927,"twenty":-1.913745,"median":-1.094479,"eighty":-0.508559,"marketCap":5069899},{"date":"2024-08-23","current":-0.572533,"twenty":-1.904683,"median":-1.080434,"eighty":-0.504719,"marketCap":5703541},{"date":"2024-08-30","current":-0.491781,"twenty":-1.902871,"median":-1.028761,"eighty":-0.504719,"marketCap":4899098},{"date":"2024-09-06","current":-0.446316,"twenty":-1.872969,"median":-0.995925,"eighty":-0.498634,"marketCap":4446170},{"date":"2024-09-13","current":-0.447771,"twenty":-1.828568,"median":-0.986483,"eighty":-0.492929,"marketCap":4460665},{"date":"2024-09-20","current":-0.458486,"twenty":-1.806821,"median":-0.986483,"eighty":-0.488525,"marketCap":4567408},{"date":"2024-09-27","current":-0.425726,"twenty":-1.803197,"median":-0.972391,"eighty":-0.483591,"marketCap":4241056},{"date":"2024-10-04","current":-0.382709,"twenty":-1.797955,"median":-0.948903,"eighty":-0.474913,"marketCap":3812528},{"date":"2024-10-11","current":-0.380413,"twenty":-1.788828,"median":-0.939508,"eighty":-0.460002,"marketCap":3789652},{"date":"2024-10-18","current":-0.447829,"twenty":-1.768764,"median":-0.901928,"eighty":-0.454812,"marketCap":4461242},{"date":"2024-10-25","current":-0.421035,"twenty":-1.747017,"median":-0.864535,"eighty":-0.451467,"marketCap":4194330},{"date":"2024-10-31","current":-0.390568,"twenty":-1.721646,"median":-0.679541,"eighty":-0.447115,"marketCap":3890813},{"date":"2024-11-08","current":-0.387353,"twenty":-1.672098,"median":-0.649036,"eighty":-0.440762,"marketCap":3858784},{"date":"2024-11-15","current":-0.381043,"twenty":-1.638553,"median":-0.603725,"eighty":-0.431797,"marketCap":3440113},{"date":"2024-11-22","current":-0.397008,"twenty":-1.635545,"median":-0.600404,"eighty":-0.42943,"marketCap":3584246},{"date":"2024-11-29","current":-0.443466,"twenty":-1.631033,"median":-0.593224,"eighty":-0.428634,"marketCap":4003679},{"date":"2024-12-06","current":-0.406469,"twenty":-1.627408,"median":-0.591753,"eighty":-0.425604,"marketCap":3669658},{"date":"2024-12-13","current":-0.397684,"twenty":-1.607491,"median":-0.589174,"eighty":-0.420859,"marketCap":3590347},{"date":"2024-12-20","current":-0.333825,"twenty":-1.585799,"median":-0.580807,"eighty":-0.418884,"marketCap":3013817},{"date":"2024-12-27","current":-0.344383,"twenty":-1.585726,"median":-0.577176,"eighty":-0.415622,"marketCap":3109143},{"date":"2025-01-03","current":-0.375722,"twenty":-1.584421,"median":-0.573602,"eighty":-0.411894,"marketCap":3392069},{"date":"2025-01-10","current":-0.331628,"twenty":-1.552453,"median":-0.572533,"eighty":-0.405083,"marketCap":2993989},{"date":"2025-01-17","current":-0.227224,"twenty":-1.531358,"median":-0.570755,"eighty":-0.401631,"marketCap":2051409},{"date":"2025-01-24","current":-0.212948,"twenty":-1.527616,"median":-0.567057,"eighty":-0.398783,"marketCap":1922528},{"date":"2025-01-31","current":-0.213033,"twenty":-1.520308,"median":-0.56186,"eighty":-0.398223,"marketCap":1923291},{"date":"2025-02-07","current":-0.326307,"twenty":-1.508705,"median":-0.560468,"eighty":-0.394676,"marketCap":2945945},{"date":"2025-02-14","current":-0.697553,"twenty":-1.494595,"median":-0.56186,"eighty":-0.397008,"marketCap":6297608},{"date":"2025-02-21","current":-0.716832,"twenty":-1.48864,"median":-0.56671,"eighty":-0.397143,"marketCap":6471662},{"date":"2025-02-28","current":-0.586313,"twenty":-1.46747,"median":-0.568521,"eighty":-0.397761,"marketCap":5257753},{"date":"2025-03-07","current":-0.551234,"twenty":-1.465633,"median":-0.567404,"eighty":-0.398147,"marketCap":4943186},{"date":"2025-03-14","current":-0.579297,"twenty":-1.465632,"median":-0.571576,"eighty":-0.398458,"marketCap":5194839},{"date":"2025-03-21","current":-0.547893,"twenty":-1.462467,"median":-0.571872,"eighty":-0.398521,"marketCap":4913228},{"date":"2025-03-28","current":-0.546223,"twenty":-1.449807,"median":-0.568521,"eighty":-0.398697,"marketCap":4898248},{"date":"2025-04-04","current":-0.490264,"twenty":-1.449214,"median":-0.56671,"eighty":-0.39874,"marketCap":4396440},{"date":"2025-04-11","current":-0.467714,"twenty":-1.445623,"median":-0.562229,"eighty":-0.39905,"marketCap":4194219},{"date":"2025-04-17","current":-0.531189,"twenty":-1.440745,"median":-0.561476,"eighty":-0.399601,"marketCap":4763434},{"date":"2025-04-25","current":-0.511144,"twenty":-1.431684,"median":-0.559586,"eighty":-0.401232,"marketCap":4583682},{"date":"2025-05-02","current":-0.547893,"twenty":-1.431684,"median":-0.554496,"eighty":-0.401897,"marketCap":4913228},{"date":"2025-05-09","current":-0.497614,"twenty":-1.413562,"median":-0.551234,"eighty":-0.40441,"marketCap":4462349},{"date":"2025-05-16","current":-0.461576,"twenty":-1.413562,"median":-0.548728,"eighty":-0.404526,"marketCap":4201708},{"date":"2025-05-23","current":-0.46931,"twenty":-1.409262,"median":-0.546223,"eighty":-0.405455,"marketCap":4272111},{"date":"2025-05-30","current":-0.445943,"twenty":-1.40538,"median":-0.543447,"eighty":-0.406266,"marketCap":4059404},{"date":"2025-06-06","current":-0.496845,"twenty":-1.397233,"median":-0.53771,"eighty":-0.408893,"marketCap":4522759},{"date":"2025-06-13","current":-0.540277,"twenty":-1.395439,"median":-0.535799,"eighty":-0.411894,"marketCap":4918124},{"date":"2025-06-20","current":-0.495806,"twenty":-1.390002,"median":-0.531215,"eighty":-0.413237,"marketCap":4513304},{"date":"2025-06-27","current":-0.495617,"twenty":-1.383197,"median":-0.530362,"eighty":-0.414341,"marketCap":4511582},{"date":"2025-07-03","current":-0.474611,"twenty":-1.379573,"median":-0.528579,"eighty":-0.415097,"marketCap":4320369},{"date":"2025-07-11","current":-0.478018,"twenty":-1.370067,"median":-0.52496,"eighty":-0.416522,"marketCap":4351377},{"date":"2025-07-18","current":-0.430519,"twenty":-1.359194,"median":-0.522988,"eighty":-0.418158,"marketCap":3918995},{"date":"2025-07-25","current":-0.427112,"twenty":-1.359194,"median":-0.51795,"eighty":-0.418696,"marketCap":3887988},{"date":"2025-08-01","current":-0.336845,"twenty":-1.359194,"median":-0.51673,"eighty":-0.414139,"marketCap":3066291},{"date":"2025-08-08","current":-0.317732,"twenty":-1.359194,"median":-0.514014,"eighty":-0.407308,"marketCap":2892304},{"date":"2025-08-15","current":-0.373717,"twenty":-1.356673,"median":-0.513303,"eighty":-0.402902,"marketCap":3497976},{"date":"2025-08-22","current":-0.357771,"twenty":-1.349134,"median":-0.511144,"eighty":-0.399188,"marketCap":3348725},{"date":"2025-08-29","current":-0.369069,"twenty":-1.339738,"median":-0.510804,"eighty":-0.398463,"marketCap":3454474},{"date":"2025-09-05","current":-0.331748,"twenty":-1.333683,"median":-0.510369,"eighty":-0.397761,"marketCap":3105149},{"date":"2025-09-12","current":-0.301281,"twenty":-1.328385,"median":-0.5091,"eighty":-0.392852,"marketCap":2819979},{"date":"2025-09-19","current":-0.294126,"twenty":-1.313887,"median":-0.507035,"eighty":-0.39037,"marketCap":2753004},{"date":"2025-09-26","current":-0.270324,"twenty":-1.312075,"median":-0.505188,"eighty":-0.388096,"marketCap":2530226},{"date":"2025-10-03","current":-0.277555,"twenty":-1.301286,"median":-0.502495,"eighty":-0.385193,"marketCap":2597905},{"date":"2025-10-10","current":-0.27153,"twenty":-1.287126,"median":-0.499591,"eighty":-0.381315,"marketCap":2541506},{"date":"2025-10-17","current":-0.265127,"twenty":-1.283368,"median":-0.498565,"eighty":-0.378882,"marketCap":2481581},{"date":"2025-10-24","current":-0.205022,"twenty":-1.268336,"median":-0.497786,"eighty":-0.375756,"marketCap":1918995},{"date":"2025-10-31","current":-0.222195,"twenty":-1.264578,"median":-0.497229,"eighty":-0.371743,"marketCap":2079734},{"date":"2025-11-07","current":-0.164499,"twenty":-1.249546,"median":-0.49594,"eighty":-0.369813,"marketCap":1539708},{"date":"2025-11-14","current":-0.130191,"twenty":-1.244292,"median":-0.495329,"eighty":-0.367813,"marketCap":1218583},{"date":"2025-11-21","current":-0.292881,"twenty":-1.223274,"median":-0.49413,"eighty":-0.364089,"marketCap":3255375},{"date":"2025-11-28","current":-0.346132,"twenty":-1.223274,"median":-0.49277,"eighty":-0.360602,"marketCap":3847261},{"date":"2025-12-05","current":-0.336033,"twenty":-1.223274,"median":-0.492175,"eighty":-0.357163,"marketCap":3735007},{"date":"2025-12-12","current":-0.352708,"twenty":-1.221454,"median":-0.491399,"eighty":-0.355787,"marketCap":3920354},{"date":"2025-12-19","current":-0.275402,"twenty":-1.211965,"median":-0.490081,"eighty":-0.35055,"marketCap":3061098},{"date":"2025-12-26","current":-0.303038,"twenty":-1.211965,"median":-0.487759,"eighty":-0.348588,"marketCap":3368271},{"date":"2026-01-02","current":-0.255883,"twenty":-1.211965,"median":-0.486862,"eighty":-0.345534,"marketCap":2844136},{"date":"2026-01-09","current":-0.293666,"twenty":-1.209203,"median":-0.485733,"eighty":-0.340605,"marketCap":3264097},{"date":"2026-01-16","current":-0.332995,"twenty":-1.204487,"median":-0.485436,"eighty":-0.33515,"marketCap":3701244},{"date":"2026-01-23","current":-0.274436,"twenty":-1.198812,"median":-0.484464,"eighty":-0.332945,"marketCap":3050357},{"date":"2026-01-30","current":-0.255979,"twenty":-1.189417,"median":-0.482559,"eighty":-0.326808,"marketCap":2845210},{"date":"2026-02-06","current":-0.202445,"twenty":-1.181455,"median":-0.479747,"eighty":-0.323981,"marketCap":2250176},{"date":"2026-02-13","current":-0.199933,"twenty":-1.172777,"median":-0.477649,"eighty":-0.317265,"marketCap":2222250},{"date":"2026-02-20","current":-0.172006,"twenty":-1.163111,"median":-0.477157,"eighty":-0.311574,"marketCap":1911844},{"date":"2026-02-27","current":-0.175871,"twenty":-1.155595,"median":-0.475221,"eighty":-0.303249,"marketCap":1954806},{"date":"2026-03-06","current":-0.260134,"twenty":-1.149958,"median":-0.474395,"eighty":-0.301547,"marketCap":2849869},{"date":"2026-03-13","current":-0.266047,"twenty":-1.12741,"median":-0.473127,"eighty":-0.300367,"marketCap":2914638},{"date":"2026-03-20","current":-0.260282,"twenty":-1.121754,"median":-0.471389,"eighty":-0.295285,"marketCap":2851488},{"date":"2026-03-27","current":-0.348817,"twenty":-1.09727,"median":-0.468512,"eighty":-0.297006,"marketCap":3821415},{"date":"2026-04-02","current":-0.357685,"twenty":-1.089829,"median":-0.467714,"eighty":-0.29808,"marketCap":3918569},{"date":"2026-04-10","current":-0.346008,"twenty":-1.080434,"median":-0.466967,"eighty":-0.300041,"marketCap":3790649},{"date":"2026-04-17","current":-0.322951,"twenty":-1.080434,"median":-0.465884,"eighty":-0.300189,"marketCap":3538047},{"date":"2026-04-24","current":-0.314674,"twenty":-1.071039,"median":-0.461576,"eighty":-0.301079,"marketCap":3447370},{"date":"2026-05-01","current":-0.363893,"twenty":-1.033459,"median":-0.459877,"eighty":-0.301281,"marketCap":3986578},{"date":"2026-05-08","current":-0.351329,"twenty":-1.024064,"median":-0.458053,"eighty":-0.301281,"marketCap":3848942},{"date":"2026-05-15","current":-0.252873,"twenty":-0.995972,"median":-0.455454,"eighty":-0.301281,"marketCap":2987504},{"date":"2026-05-22","current":-0.290564,"twenty":-0.995878,"median":-0.452281,"eighty":-0.300041,"marketCap":3432796},{"date":"2026-05-29","current":-0.281381,"twenty":-0.995878,"median":-0.447829,"eighty":-0.294913,"marketCap":3324307},{"date":"2026-06-05","current":-0.298787,"twenty":-0.988362,"median":-0.447301,"eighty":-0.295821,"marketCap":3529951},{"date":"2026-06-12","current":-0.302899,"twenty":-0.986483,"median":-0.446316,"eighty":-0.294728,"marketCap":3578528},{"date":"2026-06-18","current":-0.278228,"twenty":-0.986483,"median":-0.445806,"eighty":-0.293579,"marketCap":3287064},{"date":"2026-06-26","current":-0.227106,"twenty":-0.986483,"median":-0.443705,"eighty":-0.292701,"marketCap":2683086},{"date":"2026-07-02","current":-0.228339,"twenty":-0.982725,"median":-0.443062,"eighty":-0.290684,"marketCap":2697660},{"date":"2026-07-10","current":-0.203669,"twenty":-0.975209,"median":-0.439272,"eighty":-0.289994,"marketCap":2406196},{"date":"2026-07-17","current":-0.182013,"twenty":-0.970512,"median":-0.437993,"eighty":-0.28801,"marketCap":2150355},{"date":"2026-07-24","current":-0.174064,"twenty":-0.963935,"median":-0.435439,"eighty":-0.285768,"marketCap":2056439},{"date":"2026-07-31","current":-0.179546,"twenty":-0.95454,"median":-0.433992,"eighty":-0.284391,"marketCap":2121209},{"date":"2026-08-07","current":-0.184755,"twenty":-0.939508,"median":-0.431109,"eighty":-0.282774,"marketCap":2182740},{"date":"2026-08-14","current":-0.184711,"twenty":-0.939508,"median":-0.430519,"eighty":-0.280463,"marketCap":2266941},{"date":"2026-08-21","current":-0.625645,"twenty":-0.93575,"median":-0.430342,"eighty":-0.279558,"marketCap":7678494}],"updateTime":1787522349595},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AZTR\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2635782515","title":"Azitra, Inc. Announces Q1 2026 Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2635782515","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635782515?lang=en_us&edition=fundamental","pubTime":"2026-05-13 20:30","pubTimestamp":1778675404,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nTUA1CFPJQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AZTR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635788300","title":"Azitra Q1 FY26 net loss widens to $3.9 million; G&A expenses rise to $2.4 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635788300","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635788300?lang=en_us&edition=fundamental","pubTime":"2026-05-13 18:06","pubTimestamp":1778666806,"startTime":"0","endTime":"0","summary":"Azitra posted a net loss of $3.9 million for quarter ended March 31, 2026, widening from $3.1 million year earlier.R&D expense rose to $1.6 million from $1.3 million, while G&A costs increased to $2.4 million from $1.9 million.Cash and cash equivalents totaled $10.1 million at quarter-end.Topline data for ATR-12 Phase 1b trial in Netherton syndrome anticipated H2 2026; management cited a strengthened balance sheet and multiple near-term catalysts.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Azitra Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 13, 2026, and is solely responsi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nNDL8PtMlt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZTR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633138484","title":"Azitra wins new US patent protecting ATR-12 Netherton syndrome program","url":"https://stock-news.laohu8.com/highlight/detail?id=2633138484","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633138484?lang=en_us&edition=fundamental","pubTime":"2026-05-06 20:06","pubTimestamp":1778069202,"startTime":"0","endTime":"0","summary":"Azitra won a new U.S. patent covering ATR-12, its lead engineered S. epidermidis program for Netherton syndrome.Patent 12,606,610 B2, titled “Compositions and Methods for Treatment of Netherton Syndrome with LEKTI Expressing Recombinant Microbes,” issued April 21, 2026.Claims cover microbes that secrete one or more LEKTI protein domains, including methods of using them to treat skin diseases such as Netherton syndrome.ATR-12 is in a Phase 1b trial in adults, targeting a rare chronic disease estimated to affect about 20,000 patients globally.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nNDL7yWB28:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZTR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633813858","title":"Azitra, Inc. Announces New U.S. Patent Protecting Atr-12 Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2633813858","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633813858?lang=en_us&edition=fundamental","pubTime":"2026-05-06 20:01","pubTimestamp":1778068919,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nFWN41J0TQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AZTR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630301440","title":"Azitra presents preclinical ATR-01 data supporting first-in-human ichthyosis vulgaris trial planning","url":"https://stock-news.laohu8.com/highlight/detail?id=2630301440","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630301440?lang=en_us&edition=fundamental","pubTime":"2026-04-28 20:12","pubTimestamp":1777378326,"startTime":"0","endTime":"0","summary":"Azitra announced new preclinical results for ATR-01 in ichthyosis vulgaris will be presented at ASGCT 2026.Data support ATR-01 candidate ATR01-616 delivering functional filaggrin into skin, aiming to address underlying filaggrin deficiency.Studies showed improved skin barrier function, supporting advancement toward IND-enabling work and first-in-human testing.Program uses engineered Staphylococcus epidermidis in a topical formulation to provide localized protein delivery to affected skin.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Azitra Inc. published the original content used to generate this news brief via PR Newswire  on April 28, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDL1RyvvH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AZTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621706903","title":"Azitra prices private placement for up to USD 31 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2621706903","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621706903?lang=en_us&edition=fundamental","pubTime":"2026-03-23 21:02","pubTimestamp":1774270936,"startTime":"0","endTime":"0","summary":"Azitra entered into a securities purchase agreement with new and existing institutional investors for gross proceeds of up to USD 31.4 million.The transaction includes initial gross proceeds of about USD 10.5 million, plus up to USD 20.9 million upon potential cash exercise of warrants.Securities sold consist of 10,470 shares of Series A convertible preferred stock and warrants to purchase up to 85,101,201 shares of common stock.The Series A preferred stock was sold at USD 1,000 per share, and the warrants have an exercise price of USD 0.12 per share.The issuance was made under exemptions from registration requirements, and Azitra must register the resale of shares issuable upon conversion and warrant exercise.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, invest","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDL62xjZj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AZTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620736590","title":"Why Is Azitra Inc Stock (AZTR) Up Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2620736590","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620736590?lang=en_us&edition=fundamental","pubTime":"2026-03-20 20:36","pubTimestamp":1774010165,"startTime":"0","endTime":"0","summary":"Azitra Inc stock climbed on Friday after the company revealed details of a private placement.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/why-is-azitra-inc-stock-aztr-up-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/why-is-azitra-inc-stock-aztr-up-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AZTR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620278576","title":"Azitra Reports Private Placement Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2620278576","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620278576?lang=en_us&edition=fundamental","pubTime":"2026-03-20 01:49","pubTimestamp":1773942548,"startTime":"0","endTime":"0","summary":"Azitra  said Thursday it has struck a deal to sell about $10.5 million in convertible preferred stock to new and existing healthcare-focused institutional investors.The deal also includes funding of up to an additional $20.9 million upon exercise of warrants, the clinical-stage firm said. Investors include Stonepine Capital and Nantahala Capital, it added.Azitra said it plans to use the proceeds for research and development, working capital, and general corporate expenses. It expects to close the transaction March 20.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AZTR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620278431","title":"Azitra Inc trading resumes","url":"https://stock-news.laohu8.com/highlight/detail?id=2620278431","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620278431?lang=en_us&edition=fundamental","pubTime":"2026-03-20 01:45","pubTimestamp":1773942316,"startTime":"0","endTime":"0","summary":"13:45 EDT Azitra (AZTR) Inc trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. T...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/azitra-inc-trading-resumes-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/azitra-inc-trading-resumes-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","AZTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620588220","title":"Azitra prices private placement financing of up to USD 31.4 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2620588220","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620588220?lang=en_us&edition=fundamental","pubTime":"2026-03-20 01:14","pubTimestamp":1773940457,"startTime":"0","endTime":"0","summary":"Azitra entered into a securities purchase agreement for a private placement with gross proceeds of up to USD 31.4 million, including initial gross proceeds of USD 10.5 million.The financing includes 10,470 shares of Series A convertible preferred stock priced at USD 1,000 per share.Investors also received Series B warrants and Series C warrants to purchase up to 85,101,201 shares of common stock each, with an exercise price of USD 0.123 per share.Series A preferred shares are expected to automatically convert into about 8,129 common shares per preferred share, subject to stockholder approval and ownership limits.The company said the securities were issued under exemptions from registration requirements and it plans to register the resale of shares issuable upon conversion and warrant exercise.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDLb9jm8s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZTR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620205492","title":"Press Release: Azitra Announces Pricing of Private Placement Financing of up to Approximately $10.5 Million with up to an Additional Approximately $20.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2620205492","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620205492?lang=en_us&edition=fundamental","pubTime":"2026-03-20 01:14","pubTimestamp":1773940440,"startTime":"0","endTime":"0","summary":"Initial funding of approximately $10.5MM in convertible preferred stock and up to an additional $20.9MM upon cash exercise of warrants. Financing marks launch of Azitra new innovative protein and peptide research programs for the cosmetic and cosmeceutical markets. Leverages untapped potential of Azitra's genetic engineering platform to accelerate time to commercialization. Participating investors include institutional healthcare focused funds, Stonepine Capital and Nantahala Capital as well as other institutional funds and individual healthcare professionals, along with certain Company insiders, including the Company's Chief Executive Officer.Pursuant to the terms of the SPA, the Company is selling to investors in the financing an aggregate of  10,470 shares of Series A convertible non-redeemable preferred stock ,  Series B warrants  to purchase up to 85,101,201 shares of the Comp","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZTR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620227350","title":"Amex Halt  News Pending Lst 0.137400","url":"https://stock-news.laohu8.com/highlight/detail?id=2620227350","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620227350?lang=en_us&edition=fundamental","pubTime":"2026-03-20 00:23","pubTimestamp":1773937431,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nAQN2LQZJY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AZTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619143981","title":"Azitra Receives Notice of Non-Compliance From Nyse American and Makes Nyse American Section 610(B) Public Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=2619143981","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619143981?lang=en_us&edition=fundamental","pubTime":"2026-03-14 05:17","pubTimestamp":1773436647,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nFWN4010LU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AZTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619143624","title":"Azitra Receives NYSE American Non-Compliance Notice on Stockholders’ Equity Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2619143624","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619143624?lang=en_us&edition=fundamental","pubTime":"2026-03-14 05:15","pubTimestamp":1773436512,"startTime":"0","endTime":"0","summary":"Azitra Inc. said it received a notice of non-compliance from NYSE American for failing to meet continued listing standards tied to minimum stockholders’ equity under Sections 1003 and 1003 of the NYSE American Company Guide. The company has until April 1, 2027 to regain compliance under an accepted remediation plan, and faces potential delisting proceedings if it does not make sufficient progress. Azitra also noted its latest annual report included an auditor “going concern” paragraph, which it disclosed publicly under NYSE American Sections 410 and 610.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nNDL5gCzQw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZTR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617579559","title":"Azitra Delays Shareholder Meeting to March 6, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2617579559","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617579559?lang=en_us&edition=fundamental","pubTime":"2026-03-06 05:30","pubTimestamp":1772746227,"startTime":"0","endTime":"0","summary":"Azitra Inc. said it has canceled its special meeting of stockholders that had been scheduled for Feb. 6, 2026 and was later adjourned to March 6, 2026 due to a lack of quorum. The company announced the cancellation on March 5, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nNDLydp6v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZTR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614189892","title":"Anitra Q4 EPS $(0.81) Misses $(0.33) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2614189892","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614189892?lang=en_us&edition=fundamental","pubTime":"2026-02-28 06:38","pubTimestamp":1772231929,"startTime":"0","endTime":"0","summary":"Anitra (AMEX:AZTR) reported quarterly losses of $(0.81) per share which missed the analyst consensus estimate of $(0.33) by 149.23 percent. This is a 61.06 percent increase over losses of $(2.08) per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/02/50949678/anitra-q4-eps-0-81-misses-0-33-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Anitra Q4 EPS $(0.81) Misses $(0.33) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AZTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614898686","title":"Press Release: Azitra, Inc. Announces Full Year 2025 Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2614898686","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614898686?lang=en_us&edition=fundamental","pubTime":"2026-02-28 06:30","pubTimestamp":1772231400,"startTime":"0","endTime":"0","summary":"BRANFORD, Conn., Feb. 27, 2026 /PRNewswire/ -- Azitra, Inc.  , a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today reported financial results for the full year ended December 31, 2025, and provided a business update.-- Initiated Phase 1/2 Trial for ATR-04 program targeting oncology patients. with EGFRi-associated rash; presented ATR-04 trial design and update at. -- Announced positive preclinical data for ATR-01 program, targeting the. Mr. Salva continued: \"Also in 2025, we presented positive preclinical data for our ATR-01 program targeting ichthyosis vulgaris. Impacting approximately 1.3 million in the United States with no treatment options beyond symptom management, ichthyosis vulgaris, is an autosomal semidominant genetic disorder caused by missing or abnormal filaggrin levels. The condition is characterized by generalized xerosis and fine, white to gray scales","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AZTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614609438","title":"Azitra posts FY 2025 net loss of USD 11.0 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2614609438","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614609438?lang=en_us&edition=fundamental","pubTime":"2026-02-28 06:03","pubTimestamp":1772229821,"startTime":"0","endTime":"0","summary":"Azitra reported a FY 2025 net loss of USD 11.0 million, with R&D expenses of USD 4.8 million and G&A expenses of USD 6.2 million. Cash and cash equivalents were USD 2.1 million as of December 31, 2025. During FY 2025, Azitra initiated a Phase 1/2 trial of ATR-04 for EGFR inhibitor-associated rash and dosed the first patient in Q3 2025; topline data from the first cohort is expected around mid-2026. For its lead program ATR-12  in Netherton syndrome, the company reported promising safety data in June 2025 with 50% of patients enrolled, and said topline Phase 1b data are anticipated in H2 2026. Azitra also announced positive preclinical data for ATR-01 in ichthyosis vulgaris in Q3 2025 and said IND-enabling studies will continue in 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nNDL8S2lPz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZTR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614860947","title":"Azitra FY 2025 net loss attributable to common shareholders widens 22% to USD 11.0 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2614860947","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614860947?lang=en_us&edition=fundamental","pubTime":"2026-02-28 06:03","pubTimestamp":1772229800,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Azitra Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 27, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nNDLnRqBJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZTR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613711139","title":"Azitra Adds MD Anderson Cancer Center as ATR-04 Trial Site","url":"https://stock-news.laohu8.com/highlight/detail?id=2613711139","media":"Reuters","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613711139?lang=en_us&edition=fundamental","pubTime":"2026-02-24 21:01","pubTimestamp":1771938092,"startTime":"0","endTime":"0","summary":"Azitra Inc. has added The University of Texas MD Anderson Cancer Center as a new clinical site for its ongoing Phase 1/2 trial of ATR-04, a topical live biotherapeutic being evaluated for EGFR inhibitor-associated skin rash. The expansion is intended to broaden the study’s footprint and potentially speed patient enrollment and treatment milestones.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDLbSdPPh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZTR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":41,"code":"91000000","status":"200"}]}}